Metraipolis › archive › dc_09beeb4ce2a7
Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure — Europe PMC PMID:28489753
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/28489753
- DOI
- 10.1097/md.0000000000006769
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T04:00:47.816Z
- SHA-256 of the archived text
a156cac895c6aa30db56b76c3177e29c5a410f0e13e30c66a5c3f7219f801ce3- Stable URL of this page
https://metraipolis.com/documento/dc_09beeb4ce2a7
How to cite
Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure — Europe PMC PMID:28489753 — Europe PMC (en), https://europepmc.org/article/MED/28489753 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09beeb4ce2a7 (Metraipolis archive dc_09beeb4ce2a7, sha256 a156cac895c6aa30db56b76c3177e29c5a410f0e13e30c66a5c3f7219f801ce3)
BibTeX
@misc{dc09beeb4ce2a7,
title = {Effect of FOLFIRINOX as second-line chemotherapy for metastatic pancreatic cancer after gemcitabine-based chemotherapy failure — Europe PMC PMID:28489753},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/28489753},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09beeb4ce2a7; sha256 a156cac895c6aa30db56b76c3177e29c5a410f0e13e30c66a5c3f7219f801ce3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/28489753. Agents can read the archived copy with the MCP tool read_document.